In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Zika Virus Vaccine Hunt Begins Following 4,000 Brazilian Birth Defects

This article was originally published in Scrip

Executive Summary

The pharma industry's (and the media's) interest in Ebola has begun to wane as more affected African countries secure disease-free status from the World Health Organization, but another tropical condition has started to capture headlines – Zika virus (ZIKV), a mosquito transferred disease reportedly responsible for approximately 4,000 child birth defects since Oct. 2015.


Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts